MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6401-160-169$20.00
Mol Pharmacol 64:160-169, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dvorák, Z.
Right arrow Articles by Pascussi, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dvorák, Z.
Right arrow Articles by Pascussi, J.-M.

Colchicine Down-Regulates Cytochrome P450 2B6, 2C8, 2C9, and 3A4 in Human Hepatocytes by Affecting Their Glucocorticoid Receptor-Mediated Regulation

Zdenk Dvoák, Martin Modriansky, Lydiane Pichard-Garcia, Patrick Balaguer, Marie-Jose Vilarem, Jitka Ulrichová, Patrick Maurel, and Jean-Marc Pascussi

Institute of Medical Chemistry and Biochemistry, Medical Faculty, Palacky University Olomouc, Olomouc, Czech Republic (Z.D., M.M., J.U.); Centre National de la Recherche Scientifique (CNRS)–Institut National de la Santé et de la Recherche Médicale (INSERM) U128, Montpellier, France (Z.D., L.P.-G., M.-J.V., P.M., J.-M.P.); and CNRS–INSERM U 439, Montpellier, France (P.B.)

The xenobiotic-mediated induction of three major human liver cytochrome P450 genes, CYP2B6, CYP2C9, and CYP3A4, is known to be regulated by the constitutive androstane receptor (CAR) and the pregnane X receptor (PXR). CAR and PXR are regulated, at least in part, by the glucocorticoid receptor (GR) and the hypothesis of a signal transduction cascade GR-[CAR/PXR]-P450 has been proposed. This study was aimed at testing this hypothesis in primary human hepatocytes by using the tubulin network disrupting agent colchicine. Colchicine (COL) decreased both basal and rifampicin- and phenobarbital-inducible expression of CYP2B6, CYP2C8/9, and CYP3A4. A parallel down-regulation of mRNA expression of CAR, PXR, and tyrosine aminotransferase, a prototypic gene directly regulated by GR, was observed. COL affected neither the level of GR mRNA nor ligand binding to GR. To evaluate the effect of colchicine on GR-mediated gene transactivation, HeLa cells stably or transiently transfected with a GR-responsive element-dependent luciferase reporter gene were used. COL decreased the dexamethasone-induced luciferase expression in stably transfected cell line by 50%, whereas GR transactivation in transiently transfected cells was not affected by COL. In contrast, ligand-dependent GR translocation in the human embryonic kidney 293 cell line transiently transfected with GFP-GR was inhibited by COL. We conclude that alteration of the signal transduction mediated through the GR-[CAR/PXR]-P450 cascade by colchicine is responsible for the down-regulation of CYP2C9 and CYP3A4, implicating cytoskeleton as necessary for correct functioning of this cascade under physiological conditions.


Received December 17, 2002; accepted April 9, 2003

Address correspondence to: Dr. Jitka Ulrichová, Institute of Medical Chemistry and Biochemistry, Medical Faculty, Palacky University, Olomouc Hnvotínská 3, 77515 Olomouc, Czech Republic. Email: ulricho{at}tunw.upol.cz




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
L. Richert, G. Tuschl, C. Viollon-Abadie, N. Blanchard, A. Bonet, B. Heyd, N. Halkic, E. Wimmer, H. Dolgos, and S. O. Mueller
Species Differences in the Response of Liver Drug-Metabolizing Enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric Acid (EMD 392949) in Vivo and in Vitro
Drug Metab. Dispos., April 1, 2008; 36(4): 702 - 714.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. Siest, E. Jeannesson, J.-B. Marteau, A. Samara, B. Marie, M. Pfister, and S. Visvikis-Siest
Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
Drug Metab. Dispos., January 1, 2008; 36(1): 182 - 189.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Duret, M. Daujat-Chavanieu, J.-M. Pascussi, L. Pichard-Garcia, P. Balaguer, J.-M. Fabre, M.-J. Vilarem, P. Maurel, and S. Gerbal-Chaloin
Ketoconazole and Miconazole Are Antagonists of the Human Glucocorticoid Receptor: Consequences on the Expression and Function of the Constitutive Androstane Receptor and the Pregnane X Receptor
Mol. Pharmacol., July 1, 2006; 70(1): 329 - 339.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Mani, H. Huang, S. Sundarababu, W. Liu, G. Kalpana, A. B. Smith, and S. B. Horwitz
Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents
Clin. Cancer Res., September 1, 2005; 11(17): 6359 - 6369.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics